5.95
Schlusskurs vom Vortag:
$6.74
Offen:
$6.75
24-Stunden-Volumen:
1.11M
Relative Volume:
1.30
Marktkapitalisierung:
$39.64M
Einnahmen:
$105.38M
Nettoeinkommen (Verlust:
$17.78M
KGV:
2.2285
EPS:
2.67
Netto-Cashflow:
$-50.48M
1W Leistung:
-9.16%
1M Leistung:
+112.50%
6M Leistung:
+107.32%
1J Leistung:
+67.13%
Mei Pharma Inc Stock (MEIP) Company Profile
Firmenname
Mei Pharma Inc
Sektor
Branche
Telefon
858-369-7100
Adresse
11455 EL CAMINO REAL, SAN DIEGO, CA
Vergleichen Sie MEIP mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
MEIP
Mei Pharma Inc
|
5.95 | 44.91M | 105.38M | 17.78M | -50.48M | 2.67 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
460.83 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
558.63 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
324.79 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
595.19 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
294.51 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Mei Pharma Inc Stock (MEIP) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-07-23 | Herabstufung | Laidlaw | Buy → Hold |
2022-03-25 | Herabstufung | Jefferies | Buy → Hold |
2022-03-25 | Herabstufung | Stifel | Buy → Hold |
2022-03-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
2022-02-03 | Eingeleitet | Jefferies | Buy |
2020-09-22 | Eingeleitet | Alliance Global Partners | Buy |
2020-05-29 | Eingeleitet | SunTrust | Buy |
2018-12-20 | Eingeleitet | H.C. Wainwright | Buy |
2018-07-27 | Hochstufung | Stifel | Hold → Buy |
2018-07-13 | Eingeleitet | SunTrust | Buy |
2016-04-18 | Bestätigt | Wedbush | Neutral |
2015-03-23 | Herabstufung | ROTH Capital | Buy → Neutral |
2014-12-18 | Bestätigt | ROTH Capital | Buy |
2014-10-16 | Bestätigt | ROTH Capital | Buy |
2014-07-08 | Fortgesetzt | Brean Capital | Buy |
2013-10-22 | Bestätigt | Stifel | Buy |
2013-04-15 | Eingeleitet | Stifel | Buy |
Alle ansehen
Mei Pharma Inc Aktie (MEIP) Neueste Nachrichten
How does MEI Pharma Inc. compare to its industry peersSwing Trade Target Finder With Low Risk - jammulinksnews.com
What institutional investors are buying MEI Pharma Inc. stockConsistent double returns - jammulinksnews.com
Published on: 2025-07-28 00:30:46 - jammulinksnews.com
How many analysts rate MEI Pharma Inc. as a “Buy”Maximize your investment portfolio’s performance - jammulinksnews.com
Why MEI Pharma Inc. stock attracts strong analyst attentionFree Wealth-Building Investment Strategies - Metal.it
Can MEI Pharma Inc. stock recover from recent declineMarket Timing Advice - Metal.it
What analysts say about MEI Pharma Inc. stockDynamic profit opportunities - PrintWeekIndia
How high can MEI Pharma Inc. stock price go in 2025Free Stock Market Return Analysis - jammulinksnews.com
What drives MEI Pharma Inc. stock priceSuperior risk-adjusted returns - PrintWeekIndia
Is MEI Pharma Inc. a good long term investmentStrong return on assets - PrintWeekIndia
Will MEI Pharma Inc. stock benefit from AI tech trendsHigh Win Rate Stock Ideas - Newser
Bitcoin News Today: MEI Pharma Raises $100M for Litecoin Treasury Strategy as Corporate Crypto Holdings Surge to $108B - AInvest
Now Litecoin? Pharmaceuticals Firm Closes Deal to Fund $100M LTC Treasury - Decrypt
MEI Pharma bets 100 million yuan on Litecoin, is the altcoin micro-strategy craze coming?-web3资讯 - Odaily
Mei Pharma Plunges 9.04% Amid Litecoin Reserve Shift - AInvest
MEI Pharma's $100M Litecoin Investment Sparks 111% Stock Surge, Second $100M Raise in Works - AInvest
MEI Pharma Allocates $100M to Litecoin as Strategic Reserve Share Price Surges 172.6% After Announcement - AInvest
MEI Pharma soars after $100M litecoin treasury move, first public LTC holder on U.S. exchange - MSN
MEI Pharma Inc. Stock Analysis and ForecastFree Stock Movement Tracking - jammulinksnews.com
MEI Pharma's $100M Shift to Litecoin Treasury: A Bold Move or a Strategic Bet on Digital Assets? - AInvest
MEI Pharma Raises $100M to Buy Litecoin, First Public Company to Hold LTC as Treasury Asset - CTOL Digital Solutions
MEI Pharma’s Strategic Shift with Litecoin Treasury - TipRanks
MEI Pharma closes $100 million placement to adopt Litecoin treasury strategy - Investing.com
MEI Pharma adopts Litecoin as treasury reserve in $100 million deal - Investing.com India
MEI Pharma Allocates $100M to Litecoin, Becoming First US-Listed Company with Cryptocurrency as Primary Reserve; Coin Surges to Multi-Year High - AInvest
MEI Pharma closes $100 million placement to adopt Litecoin treasury strategy By Investing.com - Investing.com South Africa
MEI Pharma Announces Closing of $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange - Business Wire
MEI Pharma (MEIP) Becomes the First and Only Publicly Traded LTC Holder on a National Exchange - MSN
MEI Pharma Trades Cash For LTC - Asianet Newsable
Stocks in play: Enthusiast Gaming Holdings Inc. - The Globe and Mail
MEI Pharma Inc (MEIP) Stock: Navigating a Year of Volatility - investchronicle.com
How MEI Pharma Inc. stock performs during market volatilityStable Stocks With High Yield - Newser
LTC Hits Wall Street Stage: MEI Pharma's 'Litecoin Treasury' Surges Over 80% - Binance
LTC takes the stage on Wall Street: MEI Pharma's "Litecoin Vault" rises over 80%. - 富途牛牛
Bitcoin News Today: MEI Pharma Invests $100 Million in Litecoin Treasury - AInvest
Why Litecoin Soared Over the Weekend - Yahoo Finance
MEIP's Volatile Surge: A 25% Intraday Rally Sparks Market Buzz - AInvest
MEI Pharma Shares Surge After Unveiling $100 Million Litecoin Treasury Plan - MSN
MEI Pharma Invests $100 Million in Litecoin, Stock Jumps 83% - AInvest
MEI Pharma Secures $100M Investment, Acquires Litecoin, and Appoints Charlie Lee to Board. - AInvest
MEI Pharma's Pioneering Litecoin Treasury Strategy: A New Frontier in Biotech Capital Management - AInvest
Finanzdaten der Mei Pharma Inc-Aktie (MEIP)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):